Cancer
01 Jan 2013
Gemzar Prolongs Survival in Breast Cancer Trial
Eli Lilly and Co’s drug Gemzar should be more widely used to treat advanced breast cancer following a trial in which people taking it and the standard drug paclitaxel lived months longer than those taking paclitaxel alone, a researcher said on Saturday. Official Title Conditions Study Type Study Design Further…
Cancer
01 Jan 2013
The role of gemcitabine in the management of women with locally advanced and metastatic breast cancer
Prof Michael Friedlander Department of Medicine, Prince of Wales Clinical School, Randwick, NSW Cytotoxic chemotherapy plays an important role in the treatment of women with hormone-refractory or hormone-insensitive breast cancer. These agents have demonstrated benefits in providing symptom relief, temporarily reversing or delaying disease progression, and prolonging life1 with…
Cancer
01 Jan 2013
MabThera in aggressive non-Hodgkin’s lymphoma
Study of MabThera in aggressive non-Hodgkin’s lymphoma in patients less than 60 years old halted two years early due to significant efficacy benefits Official Title Conditions Study Type Study Design Further Details Study Start Eligibility & Criteria Total Enrolment Contact Details…
Cancer
01 Jan 2013
Breast Cancer – HER2 Testing Recommendations in Australia
The following is an abstract taken from Taylor and Francis Health Sciences, discussing HER2 testing recommendations in Australia. Official Title Conditions Study Type Study Design Further Details Study Start Eligibility & Criteria Total Enrolment Contact Details…
Bone
01 Jan 2013
A Study to Compare the Efficacy and Safety of Pegvisomant to that of Sandostatin LAR in Patients with Acromegaly
The pupose of the study is to determine if Pegvisomant is more efficacious than Sandostatin LAR Depot in normalizing IGF-I levels in treatment naive patients with acromegaly. Condition:- Acromegaly Study Type: InterventionalStudy Design: Treatment Eligibility Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both Criteria Other…
Blood
01 Jan 2013
Sibling Donor Cord Blood Banking and Transplantation
To develop a national cord blood bank for siblings of patients with hemoglobinopathies, thalassemia and potentially malignant diseases. Official Title Sibling Donor Cord Blood Banking and Transplantation Conditions – Blood Disease- Anemia, Sickle Cell- Anemia (Cooley’s)- Leukemia- Bone Marrow Transplantation- Hematopoietic Stem Cell Transplantation Study Type Interventional Study Design…
Blood
01 Jan 2013
A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples. Official Title A Test to Predict the Hemolytic Potential of Drugs…
Blood
01 Jan 2013
Severe Hemophilia A Study
To characterize the safety and efficacy of ReFacto AF in treating acute bleeding episodes during prophylaxis treatment, including neoantigenicity. Official Title An Open-label Study to Characterize the Safety and Efficacy of BDDrFVIII Manufactured by the Albumin Free Process (ReFacto AF) in the Treatment of Previously Treated Patients (PTP) with Severe…
Blood
01 Jan 2013
Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected with HIV
The purpose of this study is to find out whether these powerful combinations of anti-HIV drugs are safe and effective for use in patients in the early stages of HIV infection and to find out how patients’ immune systems react to HIV and anti-HIV drugs. Doctors generally treat patients in…
